Search research articles
Contact Us
Filters
Showing results (101-110 of 237) with videos related to
Page
of 24
Sort By:
Breast Cancer Research and Treatment
|
September 22, 2014
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
Tom Wei-Wu Chen, Ho-Min Chen, Ching-Hung Lin, et al.
Cancer
|
November 2, 2002
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
Chiun Hsu, Chiun-Sheng Huang, Tsu-Yi Chao, et al.
Spine
|
January 4, 2014
Subpedicle decompression and vertebral reconstruction for thoracolumbar Magerl incomplete burst fractures via a minimally invasive method
Kung-Chia Li, Shang-Won Yu, Allen Li, et al.
Anticancer Research
|
January 30, 2003
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
Chih-Hung Hsu, Ann-Lii Cheng, Chiun Hsu, et al.
Yi Chuan = Hereditas
|
July 5, 2006
[Characteristics and Influencing factors of Sperm Interaction with Exogenous DNA]
Hua-Hu Ye, Yan Liu, Zhu-Guo Liu, et al.
Materials Science & Engineering. C, Materials for Biological Applications
|
December 19, 2016
Enhanced antimicrobial activities of silver-nanoparticle-decorated reduced graphene nanocomposites against oral pathogens
Jian-Min Peng, Jia-Cheng Lin, Zhuo-Yu Chen, et al.
Oncology
|
August 10, 2005
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
Kun-Huei Yeh, Yen-Shen Lu, Chih-Hung Hsu, et al.
The Oncologist
|
March 5, 2025
Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study
Chiao Lo, Dwan-Ying Chang, Yen-Shen Lu, et al.
The Journal of Biological Chemistry
|
March 6, 2009
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
Kuen-Feng Chen, Pei-Yen Yeh, Chiun Hsu, et al.
Oncoimmunology
|
March 28, 2017
Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells
Bijun Cui, Shen Lu, Lihua Lai, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 237) with videos related to
Sort By:
Page
of 24
Breast Cancer Research and Treatment
|
September 22, 2014
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
Tom Wei-Wu Chen, Ho-Min Chen, Ching-Hung Lin, et al.
Cancer
|
November 2, 2002
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
Chiun Hsu, Chiun-Sheng Huang, Tsu-Yi Chao, et al.
Spine
|
January 4, 2014
Subpedicle decompression and vertebral reconstruction for thoracolumbar Magerl incomplete burst fractures via a minimally invasive method
Kung-Chia Li, Shang-Won Yu, Allen Li, et al.
Anticancer Research
|
January 30, 2003
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
Chih-Hung Hsu, Ann-Lii Cheng, Chiun Hsu, et al.
Yi Chuan = Hereditas
|
July 5, 2006
[Characteristics and Influencing factors of Sperm Interaction with Exogenous DNA]
Hua-Hu Ye, Yan Liu, Zhu-Guo Liu, et al.
Materials Science & Engineering. C, Materials for Biological Applications
|
December 19, 2016
Enhanced antimicrobial activities of silver-nanoparticle-decorated reduced graphene nanocomposites against oral pathogens
Jian-Min Peng, Jia-Cheng Lin, Zhuo-Yu Chen, et al.
Oncology
|
August 10, 2005
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
Kun-Huei Yeh, Yen-Shen Lu, Chih-Hung Hsu, et al.
The Oncologist
|
March 5, 2025
Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study
Chiao Lo, Dwan-Ying Chang, Yen-Shen Lu, et al.
The Journal of Biological Chemistry
|
March 6, 2009
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
Kuen-Feng Chen, Pei-Yen Yeh, Chiun Hsu, et al.
Oncoimmunology
|
March 28, 2017
Protective function of interleukin 27 in colitis-associated cancer via suppression of inflammatory cytokines in intestinal epithelial cells
Bijun Cui, Shen Lu, Lihua Lai, et al.
Page
of 24